Indian Immunologicals Limited
↗Hyderabad, India
Indian Immunologicals Limited (IIL) is a leading biologicals company and a wholly-owned subsidiary of the National Dairy Development Board (NDDB). Established in 1982, IIL was founded with the objective of making modern technology available to Indian farmers at affordable costs. It has since grown into one of the largest producers of Foot and Mouth Disease (FMD) vaccines globally and a major player in the human vaccine market.
The company operates across two primary segments: Animal Health and Human Health. IIL is the market leader in the veterinary biologicals sector in India and exports its products to over 50 countries. It is particularly renowned for its 'Raksha' brand of veterinary vaccines and 'Abhayrab', the world's largest selling anti-rabies vaccine for humans.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$150M-$200M
Founded:1982
Ownership:subsidiary
Status:operating
FUNDING
Investors:National Dairy Development Board (NDDB)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Vaccines (Inactivated), Vaccines (Live Attenuated), Recombinant Proteins, Sera
Active Trials:5
Trial Phases:Phase 1: 1 | Phase 2: 2 | Phase 3: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:National Dairy Development Board (NDDB)
Subsidiaries:Pristine Biologicals (NZ) Ltd
Key Partnerships:Griffith University (Zika vaccine development), CSIRO (Animal health research), National Institute of Animal Biotechnology (NIAB)
COMPETITION
Position:Leader
Competitors:Serum Institute of India, Bharat Biotech, Hester Biosciences, Zoetis (Animal Health), MSD Animal Health
LEADERSHIP
Key Executives:
Dr. K. Anand Kumar - Managing Director
Dr. Priyabrata Pattnaik - Deputy Managing Director
Scientific Founders:Dr. Verghese Kurien (via NDDB)
Board Members:Meenesh Shah (Chairman)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Indian Immunologicals Limited. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.